Skip to content Home / Companies / BCRX BCR
BIOCRYST PHARMACEUTICALS INC (BCRX) XNAS BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Net insider buying (90d)
Latest BCRX Insider Trades
About BIOCRYST PHARMACEUTICALS INC (BCRX) BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Headquarters DURHAM, NC
Employees 435
Listed 1994
Exchange XNAS https://www.biocryst.com SEC filings for BCRX on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Grant or award 23 444,414
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
BCRX Insider Transactions (Form 4) 57 60 Form 4 filings on record, the earliest from Dec 2, 2024, newest first. Filing history page 2 of 2.
Date Insider Transaction Security Shares Price Value Dec 17, 2025 AB Alane P. Barnes - Officer Grant or award Common Stock 121,700
Recent BCRX Form 8-K Filings 5
Recent BCRX Form 144 Notices of Proposed Sale 2 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice May 18, 2026 - - - - View on EDGAR May 13, 2026 - - -
BCRX Insider Trading - FAQ
What is the latest insider trade for BCRX? BIOCRYST PHARMACEUTICALS INC (BCRX) had 14 insider filings in the last 90 days, with the most recent on 2026-06-15. The full record for BCRX runs to 60 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BCRX stock? No insider purchases of BCRX were filed in the last 90 days.
How many insiders are selling BCRX stock? No insider sales of BCRX were filed in the last 90 days. 12 sales are on record for this company.
Where can I see BCRX SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BCRX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BCRX insider buys? Create a free InsiderAlpha account and press Watch on this page to add BCRX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BCRX insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free
Market cap $2.51B
P/E ratio -
Dividend yield -
Average volume 4.29M
52 week high $11.22
52 week low $6.00
Today's high $9.96
Today's low $9.72
Open $9.82
Volume 2.70M
Previous close $9.87
Shares outstanding 255.54M Market cap
$2.51B
435 employees
Most-Active BCRX Insiders - Last 90 Days 10 Dec 17, 2025 AB Alane P. Barnes - Officer Grant or award Emp. Stock Option (Right to Buy) 255,050 $0.00 -
Dec 17, 2025 BG Babar Ghias - Officer Grant or award Common Stock 121,700 $0.00 -
Dec 17, 2025 BG Babar Ghias - Officer Grant or award Emp. Stock Option (Right to Buy) 355,050 $0.00 -
Dec 12, 2025 CG Charles K. Gayer - Officer Tax withholding / forfeiture Common Stock 8,181 $7.57 $62K
Dec 12, 2025 AB Alane P. Barnes - Officer Tax withholding / forfeiture Common Stock 8,540 $7.57 $65K
Dec 15, 2025 AB Alane P. Barnes - Officer Open-market sale Common Stock 21,210 $7.65 $162K
Dec 12, 2025 JS Jon P. Stonehouse - Officer Tax withholding / forfeiture Common Stock 27,368 $7.57 $207K
Dec 1, 2025 AB Alane P. Barnes - Officer Option exercise Common Stock 91,004 $3.22 $293K
Dec 1, 2025 AB Alane P. Barnes - Officer Open-market sale Common Stock 91,004 $7.10 $647K
Dec 2, 2025 AB Alane P. Barnes - Officer Open-market sale Common Stock 50,906 $7.21 $367K
Dec 3, 2025 AB Alane P. Barnes - Officer Open-market sale Common Stock 19,770 $7.65 $151K
Dec 1, 2025 AB Alane P. Barnes - Officer Option exercise Emp. Stock Option (Right to Buy) 91,004 $0.00 -
Nov 28, 2025 SF Steven Frank - Director Grant or award Common Stock 1,566 $7.18 $11K
Nov 28, 2025 VM Vincent Milano - Director Grant or award Common Stock 783 $7.18 $6K
Nov 28, 2025 AM Amy E. McKee - Director Grant or award Common Stock 783 $7.18 $6K
Nov 13, 2025 MS Machelle Sanders - Director Open-market sale Common Stock 9,600 $7.14 $69K
Aug 29, 2025 VM Vincent Milano - Director Grant or award Common Stock 676 $8.31 $6K
Aug 29, 2025 AM Amy E. McKee - Director Grant or award Common Stock 676 $8.31 $6K
Aug 29, 2025 SF Steven Frank - Director Grant or award Common Stock 1,353 $8.31 $11K
Aug 13, 2025 TH Theresa Heggie - Director Option exercise Common Stock 30,000 $2.91 $87K
Aug 13, 2025 TH Theresa Heggie - Director Option exercise Common Stock 40,000 $5.41 $216K
Aug 13, 2025 TH Theresa Heggie - Director Open-market sale Common Stock 70,000 $8.51 $596K
Aug 13, 2025 TH Theresa Heggie - Director Option exercise Automatic Stock Option Grant 30,000 $0.00 -
Aug 13, 2025 TH Theresa Heggie - Director Option exercise Automatic Stock Option Grant 40,000 $0.00 -
Jul 24, 2025 BG Babar Ghias - Officer Grant or award Common Stock 147,000 $0.00 -
Jul 24, 2025 BG Babar Ghias - Officer Grant or award Emp. Stock Option (Right to Buy) 305,000 $0.00 -
Jun 12, 2025 VM Vincent Milano - Director Grant or award Common Stock 12,500 $0.00 -
Jun 12, 2025 VM Vincent Milano - Director Grant or award Automatic Stock Option Grant 27,181 $0.00 -
Jun 12, 2025 AL Alan G. Levin - Director Grant or award Common Stock 12,500 $0.00 -
Jun 12, 2025 AL Alan G. Levin - Director Grant or award Automatic Stock Option Grant 27,181 $0.00 -
May 30, 2025 VM Vincent Milano - Director Grant or award Common Stock 523 $10.75 $6K
Dec 19, 2024 AD Anthony Doyle - Officer Grant or award Common Stock 120,700 $0.00 -
Dec 19, 2024 AD Anthony Doyle - Officer Tax withholding / forfeiture Common Stock 2,461 $7.39 $18K
Dec 19, 2024 AD Anthony Doyle - Officer Grant or award Emp. Stock Option (Right to Buy) 250,100 $0.00 -
Dec 19, 2024 AB Alane P. Barnes - Officer Grant or award Common Stock 120,700 $0.00 -
Dec 19, 2024 AB Alane P. Barnes - Officer Tax withholding / forfeiture Common Stock 2,461 $7.39 $18K
Dec 19, 2024 AB Alane P. Barnes - Officer Grant or award Emp. Stock Option (Right to Buy) 250,100 $0.00 -
Dec 19, 2024 JS Jon P. Stonehouse - Officer Tax withholding / forfeiture Common Stock 14,010 $7.39 $104K
Dec 19, 2024 JS Jon P. Stonehouse - Officer Grant or award Emp. Stock Option (Right to Buy) 750,250 $0.00 -
Dec 19, 2024 HT Helen M. Thackray - Officer Tax withholding / forfeiture Common Stock 6,096 $7.39 $45K
Dec 19, 2024 HT Helen M. Thackray - Officer Grant or award Emp. Stock Option (Right to Buy) 260,950 $0.00 -
Dec 19, 2024 CG Charles K. Gayer - Officer Tax withholding / forfeiture Common Stock 2,461 $7.39 $18K
Dec 19, 2024 CG Charles K. Gayer - Officer Grant or award Emp. Stock Option (Right to Buy) 260,950 $0.00 -
Dec 14, 2024 AB Alane P. Barnes - Officer Tax withholding / forfeiture Common Stock 8,613 $7.53 $65K
Dec 14, 2024 AD Anthony Doyle - Officer Tax withholding / forfeiture Common Stock 7,890 $7.53 $59K
Dec 14, 2024 CG Charles K. Gayer - Officer Tax withholding / forfeiture Common Stock 8,251 $7.53 $62K
Dec 14, 2024 JS Jon P. Stonehouse - Officer Tax withholding / forfeiture Common Stock 27,525 $7.53 $207K
Dec 14, 2024 HT Helen M. Thackray - Officer Tax withholding / forfeiture Common Stock 7,150 $7.53 $54K
Dec 13, 2024 NH Nancy J. Hutson - Director Open-market sale Common Stock 7,000 $7.54 $53K
Nov 29, 2024 VM Vincent Milano - Director Grant or award Common Stock 750 $7.50 $6K
